These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The COMET Initiative database: progress and activities from 2011 to 2013. Gargon E; Williamson PR; Altman DG; Blazeby JM; Clarke M Trials; 2014 Jul; 15():279. PubMed ID: 25012001 [TBL] [Abstract][Full Text] [Related]
4. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. Sinha IP; Smyth RL; Williamson PR PLoS Med; 2011 Jan; 8(1):e1000393. PubMed ID: 21283604 [TBL] [Abstract][Full Text] [Related]
5. The past is the future: innovative designs in acute stroke therapy trials. Krams M; Lees KR; Berry DA Stroke; 2005 Jun; 36(6):1341-7. PubMed ID: 15879340 [No Abstract] [Full Text] [Related]
6. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables. Jiang Z; Song Y; Shou Q; Xia J; Wang W Trials; 2014 Dec; 15():500. PubMed ID: 25528466 [TBL] [Abstract][Full Text] [Related]
7. Monitoring in clinical trials: benefit or bias? Nardini C Theor Med Bioeth; 2013 Aug; 34(4):259-74. PubMed ID: 23824468 [TBL] [Abstract][Full Text] [Related]
8. How can we improve clinical trials? Kaplan RS Nat Clin Pract Oncol; 2007 Apr; 4(4):206-7. PubMed ID: 17392712 [No Abstract] [Full Text] [Related]
10. Inference and decision in clinical trials. Armitage P J Clin Epidemiol; 1989; 42(4):293-9. PubMed ID: 2723689 [No Abstract] [Full Text] [Related]
11. Outcomes and endpoints in trials of cancer treatment: the past, present, and future. Wilson MK; Karakasis K; Oza AM Lancet Oncol; 2015 Jan; 16(1):e32-42. PubMed ID: 25638553 [TBL] [Abstract][Full Text] [Related]
12. What is the logic in mixing data and beliefs? Brown PM Pharm Stat; 2007; 6(1):5-8. PubMed ID: 17256805 [No Abstract] [Full Text] [Related]
13. Statistical considerations for the next generation of clinical trials. Wu W; Shi Q; Sargent DJ Semin Oncol; 2011 Aug; 38(4):598-604. PubMed ID: 21810519 [TBL] [Abstract][Full Text] [Related]
14. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials. Teramukai S; Daimon T; Zohar S Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115 [TBL] [Abstract][Full Text] [Related]
15. [Present and future of trial design]. Vargas Vorácková F Rev Invest Clin; 1990 Jul; 42 Suppl():36-8. PubMed ID: 19256131 [TBL] [Abstract][Full Text] [Related]
16. Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update. Tidwell RSS; Peng SA; Chen M; Liu DD; Yuan Y; Lee JJ Clin Trials; 2019 Dec; 16(6):645-656. PubMed ID: 31450957 [TBL] [Abstract][Full Text] [Related]
17. Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints. Yu Z; Ramakrishnan V; Meinzer C J Biopharm Stat; 2019; 29(2):306-317. PubMed ID: 30763151 [TBL] [Abstract][Full Text] [Related]
18. The new math of clinical trials. Couzin J Science; 2004 Feb; 303(5659):784-6. PubMed ID: 14764863 [No Abstract] [Full Text] [Related]
19. Data handling in cancer clinical trials-how we can minimize potential biases. Sakamoto J; Teramukai S Jpn J Clin Oncol; 2002 Jan; 32(1):1-2. PubMed ID: 11932354 [No Abstract] [Full Text] [Related]
20. Comments on 'Current issues in non-inferiority trials' by Thomas R. Fleming, Statistics in Medicine, DOI: 10.1002/sim.2855. Koch GG Stat Med; 2008 Feb; 27(3):333-42. PubMed ID: 17530625 [No Abstract] [Full Text] [Related] [Next] [New Search]